Sanofi US Issues Voluntary Nationwide Recall of ALL Auvi‑Q® Due to Potential Inaccurate Dosage Delivery More questions? Click here for additional information. > Due to high volume of calls being received on the Auvi‑Q customer… Read More »Sanofi US Issues Voluntary Nationwide Recall of ALL Auvi‑Q® Due to Potential Inaccurate Dosage Delivery
Consensus Communication on Early Peanut Introduction and the Prevention of Peanut Allergy in High-Risk Infants On behalf of American Academy of Asthma Allergy and Immunology, American Academy of Pediatrics, American College of Allergy, Asthma &… Read More »Update on Early Peanut Introduction and Prevention of Allergy
A recent abstract promoted at the American Thoracic Society meeting on the topic of children with asthma being prone to peanut sensitization. The authors suggest children who do have asthma are more likely to be… Read More »Asthma and Peanut Allergy
The hygiene hypothesis is the most common theory for increased food allergy. It begins with a lack of early childhood exposure to infections. Without proper stimuli the immune system does not receive necessary education. When presented with food proteins,… Read More »Antibiotics and food allergy induction
Chronic hives are a common problem in the general population and in my practice. Children and adults can suffer daily itching and hives for months or years without explanation. However, symptoms often resolve spontaneously and… Read More »Allergic reactions without answers
The FDA has approved the first product for oral immunotherapy! Oralair is a tablet containing five grass allergens; Sweet Vernal, Orchard, Perennial Rye, Timothy and Kentucky Blue Grass. It is manufactured by Stallergenes, a French pharmaceutical… Read More »Update: Oralair approved for grass pollen allergy
It is clear to those suffering, allergies cause stress. Constant runny nose, decreased quality of sleep, missed days at school and work are among the many reasons why. A new study from Ohio State University* flips this… Read More »Stress & Allergy
Eosinophilic esophagitis (EoE) is an inflammatory condition affecting the esophagus (the tube that connects the throat with the stomach). The esophagus contains too high a number of eosinophils, an allergic white blood cell. This causes several gastrointestinal… Read More »What is Eosinophilic Esophagitis?
The FDA has approved omalizumab (Xolair) for the treatment of chronic hives. This is the first medication with a specific indication for [glossary slug=’chronic-idiopathic-urticaria’ /] (CIU). There are many patients with CIU that remain symptomatic,… Read More »Xolair approved for chronic hives
Allergies are common and costly. Total costs are in the billions. An increasing proportion of this number is being shifted to the patient, in the form of higher copays and deductibles. The price of health… Read More »Allergy shots, a new source of savings
